ATE316384T1 - Neue dialysemethode - Google Patents

Neue dialysemethode

Info

Publication number
ATE316384T1
ATE316384T1 AT00901367T AT00901367T ATE316384T1 AT E316384 T1 ATE316384 T1 AT E316384T1 AT 00901367 T AT00901367 T AT 00901367T AT 00901367 T AT00901367 T AT 00901367T AT E316384 T1 ATE316384 T1 AT E316384T1
Authority
AT
Austria
Prior art keywords
dialysis method
new dialysis
treatment
molecular weight
low molecular
Prior art date
Application number
AT00901367T
Other languages
English (en)
Inventor
Gunnar Fager
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE316384T1 publication Critical patent/ATE316384T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424—Substitution fluid path
    • A61M1/3427—Substitution fluid path back through the membrane, e.g. by inverted trans-membrane pressure [TMP]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672—Means preventing coagulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)
AT00901367T 1999-01-11 2000-01-11 Neue dialysemethode ATE316384T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900043A SE9900043D0 (sv) 1999-01-11 1999-01-11 New use

Publications (1)

Publication Number Publication Date
ATE316384T1 true ATE316384T1 (de) 2006-02-15

Family

ID=20414050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00901367T ATE316384T1 (de) 1999-01-11 2000-01-11 Neue dialysemethode

Country Status (19)

Country Link
US (4) US20030042202A1 (de)
EP (1) EP1144000B1 (de)
JP (1) JP4054533B2 (de)
KR (1) KR100840452B1 (de)
CN (1) CN100387296C (de)
AT (1) ATE316384T1 (de)
AU (1) AU763185B2 (de)
BR (1) BR0007448A (de)
CA (1) CA2356440A1 (de)
CY (1) CY1107461T1 (de)
DE (1) DE60025698T2 (de)
DK (1) DK1144000T3 (de)
ES (1) ES2255968T3 (de)
IL (1) IL143824A0 (de)
NO (1) NO326996B1 (de)
NZ (1) NZ512712A (de)
SE (1) SE9900043D0 (de)
WO (1) WO2000041715A1 (de)
ZA (1) ZA200105274B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112572B2 (en) 2002-09-09 2006-09-26 Trigen Limited Multivalent metal salts of boronic acids
AU2003263343A1 (en) 2002-09-09 2004-03-29 Trigen Limited Boronic acid salts ant their use in the treatment of thromobis
US7235589B2 (en) * 2004-09-21 2007-06-26 Bio Numerik Pharmaceuticals, Inc. Method of treating patients undergoing kidney dialysis
CN105115949B (zh) * 2005-12-21 2018-06-22 梅索斯卡莱科技公司 分析装置、方法和试剂
MX338460B (es) 2005-12-21 2016-04-15 Meso Scale Technologies Llc Aparatos, metodos y reactivos de ensayo.
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
EP3165245B1 (de) * 2011-08-02 2019-02-20 Medtronic, Inc. Hämodialysesystem mit einem durchflussweg mit gesteuertem nachgiebigem volumen
US10010663B2 (en) 2013-02-01 2018-07-03 Medtronic, Inc. Fluid circuit for delivery of renal replacement therapies
US9623164B2 (en) 2013-02-01 2017-04-18 Medtronic, Inc. Systems and methods for multifunctional volumetric fluid control
US10850016B2 (en) 2013-02-01 2020-12-01 Medtronic, Inc. Modular fluid therapy system having jumpered flow paths and systems and methods for cleaning and disinfection
US10098993B2 (en) 2014-12-10 2018-10-16 Medtronic, Inc. Sensing and storage system for fluid balance
US9713665B2 (en) 2014-12-10 2017-07-25 Medtronic, Inc. Degassing system for dialysis
US10874787B2 (en) 2014-12-10 2020-12-29 Medtronic, Inc. Degassing system for dialysis
US11278654B2 (en) 2017-12-07 2022-03-22 Medtronic, Inc. Pneumatic manifold for a dialysis system
US11033667B2 (en) 2018-02-02 2021-06-15 Medtronic, Inc. Sorbent manifold for a dialysis system
US11110215B2 (en) 2018-02-23 2021-09-07 Medtronic, Inc. Degasser and vent manifolds for dialysis
US12128165B2 (en) 2020-04-27 2024-10-29 Mozarc Medical Us Llc Dual stage degasser
DE102023117587A1 (de) * 2023-07-04 2025-01-09 Fresenius Medical Care Deutschland Gmbh Zusammensetzung für Dialyselösung und Sensorikeinheit

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
US4489535A (en) * 1980-10-02 1984-12-25 Veltman Preston Leonard Materials and method for preparing dialysis solutions containing bicarbonate ions
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
US5380299A (en) * 1993-08-30 1995-01-10 Med Institute, Inc. Thrombolytic treated intravascular medical device
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
DE4443390A1 (de) * 1994-12-06 1996-06-13 Basf Ag Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
AU706834B2 (en) * 1995-02-10 1999-06-24 Abbott Gmbh & Co. Kg Thrombin inhibitors
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
SE9600216D0 (sv) * 1996-01-18 1996-01-18 Hans Arne Hansson Styrning av läkningsprocesser
AU719216B2 (en) * 1996-02-13 2000-05-04 Akzo Nobel N.V. Serine protease inhibitors
EP0884325A1 (de) * 1997-04-24 1998-12-16 Akzo Nobel N.V. Inhibitoren des Thrombins, die einen peptid-Heterocyclus aufweisen
ATE286395T1 (de) * 1997-04-30 2005-01-15 Lilly Co Eli Antithrombotische mittel
CA2287984A1 (en) * 1997-05-01 1998-11-05 Gerald Floyd Smith Antithrombotic agents
PL336589A1 (en) * 1997-05-02 2000-07-03 Akzo Nobel Nv Serinic protease inhibitors

Also Published As

Publication number Publication date
NO20013301L (no) 2001-07-03
ES2255968T3 (es) 2006-07-16
BR0007448A (pt) 2001-10-16
ZA200105274B (en) 2002-09-26
US20090192137A1 (en) 2009-07-30
JP2002534217A (ja) 2002-10-15
US20080004225A1 (en) 2008-01-03
JP4054533B2 (ja) 2008-02-27
DE60025698D1 (de) 2006-04-13
US20030042202A1 (en) 2003-03-06
EP1144000A1 (de) 2001-10-17
NO20013301D0 (no) 2001-07-03
SE9900043D0 (sv) 1999-01-11
AU2140900A (en) 2000-08-01
AU763185B2 (en) 2003-07-17
KR20010093250A (ko) 2001-10-27
WO2000041715A1 (en) 2000-07-20
DK1144000T3 (da) 2006-05-08
CN100387296C (zh) 2008-05-14
NO326996B1 (no) 2009-03-30
EP1144000B1 (de) 2006-01-25
DE60025698T2 (de) 2006-10-19
US20050153904A1 (en) 2005-07-14
KR100840452B1 (ko) 2008-06-20
CA2356440A1 (en) 2000-07-20
CN1354673A (zh) 2002-06-19
IL143824A0 (en) 2002-04-21
CY1107461T1 (el) 2012-12-19
NZ512712A (en) 2004-09-24

Similar Documents

Publication Publication Date Title
DE60025698D1 (de) Neue dialysemethode
DK1218039T3 (da) Anvendelse af dialysat med höjt citratindhold
BR0116519B1 (pt) cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria.
SE9702860L (sv) Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
YU16902A (sh) Farmaceutski rastvori levosimendana
DE60133893D1 (de) Kathetersperrlösung mit photo-oxidant
EA200400548A1 (ru) Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)
DK1509231T3 (da) System til peritonealdialyse omfattende et reservoir til dialyseopløsning og en patron, der indeholder taurolidinpulver
DK0951470T3 (da) Fremgangsmåde og farmaceutisk sammensætning til tilförsel af jern til hæmodialyse og peritonealdialysepatienter
SE9902597D0 (sv) New use
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
NZ514911A (en) Use of N-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients
ATE482705T1 (de) Antibakterielle behandlung von osteoarthritis
EP1847527A4 (de) Neue benzamidinverbindungen
SE0203349D0 (sv) New use
DE60117762D1 (de) Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patienten
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
MX2007003120A (es) Metodo y composicion para el tratamiento de pacientes que se someten a dialisis de rinon.
GB0007239D0 (en) Use
UA3797U (uk) Спосіб лікування тяжких проникаючих поранень ока
NO20043774L (no) The use of devazenide as analgesic agent
MD2664G2 (ro) Metodă de tratament a peritonitelor generalizate purulente
HK1051976A (en) The use of anticoagulant agents in the extracorporeal treatment of blood
RU2003135700A (ru) Способ лечения хирургической инфекции
DK1311286T3 (da) Behandling af hepatitis C med thymosin og pegyleret interferon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1144000

Country of ref document: EP